# v6 Routed AI Trace — m003-POS-02 (blinded)
## Automated medication-dispensing cabinet (ADC) — guarantee: NEVER administer the wrong medication (6 nursing units, 8-week window, fixed hardware)
### META (routing — blind router output)
- Signature: d:engineering,finance,medical,security,software | g:diagnose,guarantee,maximize,predict | c:(none)
- Router top3: m003, m031, m040; confidence gap <= 0.5 → AMBIGUOUS → DUAL-ROUTE: m003 + m031 first-class passes, synthesized (m040 = router context only: leverage-point ranking). Gate (R3): m003 inversion, full-strength (guarantee goal; R4 cap does not apply). Flags: no deadline → tempo off; advisory deliverable, not fully specified → no P8 fast path.
### WHAT — frame + structure-first scan (S1)
- Goal-type check (P5): "NEVER" is a guarantee mandate, not a maximization → full-strength inversion enumeration, no top-5 cap (the maximize cap explicitly not applied). Frame (inverted): "How do we make absolutely sure the wrong medication IS administered?" — each answer is a line of defense. Deliverable = categorized ranked failure inventory → prevent/detect/respond per top mode → bounded residual + monitoring.
### WHY — P1 input-provenance audit
- GIVEN/trust: cabinet hardware as-purchased, HL7 order feed, nurse barcode scanning, 8 weeks. REFERENCE BASE RATES (P10 ordering authority — not measured on this stack): medication-error epidemiology — identity and human-factor errors dominate, interface errors high-impact but rarer, hardware smallest class. UNMEASURED: no site-specific incident history for this device. INTERESTED PARTY: the CEO's "NEVER" is mandate phrasing, not a measured bound → convert to an SLA at WHAT, never execute against a literal zero.
### HOW — style passes (dual-route, synthesize)
- Pass S1 (m003 inversion, completion contract §II.2.9): ≥6 failure categories from the inverted question, category-first, concrete example each — (1) data/interface: HL7 order-feed mapping error / mis-keyed NDC-to-drawer library (amlodipine truncated → amiodarone drawer); (2) physical stocking: look-alike packs, wrong drawer load; (3) patient identity: wrong/borrowed wristband scan, bed-switch mid-shift; (4) human use: override/bypass path, interrupted-flow wrong-patient pick; (5) software logic: allergy-check misconfiguration, silent fallback, offline degraded mode; (6) hardware/environment: barcode misread, drawer-sensor misfire, power loss; (7) process/governance: untrained staff, maintenance windows, formulary additions without library update, no near-miss loop; (8) timing/state: med after discontinuation, stat bypass. 8/8 distinct — contract met.
- Rank by L×I: override/bypass (1) > identity (2) > data/interface (3) > degraded-mode (4) > stocking (5) > governance (6) > hardware (7) > timing (8). Top-5 each get ≥1 mitigation tagged P/D/R: two-person override with real-time alert, auto-quarantine, high-risk-med disable; non-skippable scan-before-draw, block after 3 failed scans; pharmacist-signed dual-mapped library + order-feed reconciliation; offline mode = two-nurse verification, timeboxed, 30-min escalate; barcode-verified drawer loading + load-error stock-hold.
- Never/always reframing stated ✓: "NEVER" is a target function, not a risk — bounded residual target with defense-in-depth; never ship an unmonitored guarantee; always treat ambiguous scan/timeout as unresolved, never as verified.
- Pass S2 (m031 scientific method, dual-route): the risk picture is a hypothesis until deployment — each category names its own discriminating probe (override-event rate, failed-scan block rate, feed-mismatch count, load-error rate); controlled observation via daily reconciliation + trigger-event monitoring; update rule: re-weight mitigation spend on the 90-day incident mix. m040 context: highest-leverage point = the override/bypass path — one control reaches both dominant L×I modes.
- Divergence resolution (V2): general route's defense-in-depth agrees with the pass → proceed; agreement recorded; no unresolved disagreement.
### GATES — m003 inversion (R3, mandatory)
- Contract re-checked: ≥6 ranked categories ✓ (8); un-mitigable residual named ✓ — upstream stocking with human workarounds (pharmacist loads wrong pack, bypasses barcode-verified loading): no downstream software check catches a correctly-packed wrong drug → detect-and-remediate only, prevention stops at the pharmacy boundary; never/always ✓. Evidence-weighting (router context): mitigations 1–4 rest on strong industry base rates; 7–8 weak → detect-tier, not prevent-tier.
### DO — P3 branch-completeness before commit
- Advisory (A2), no live system touched. Failure branch priced: if dual-mapping + feed reconciliation cannot land in 8 weeks → ship detection-first (reconciliation sweeps + auto-hold), phase prevent layers at week 12, residual ×3 during the gap; if offline-mode policy cannot ship → block offline dispensing until review. Commit: 8-category inventory, top-5 P/D/R spine, sentinel-event monitoring suite (override, failed-scan, mismatch, load-error) with auto-quarantine + pharmacist paging, target ≤1 wrong-medication event per 10^5 doses, quarterly review.
### REVIEW — insight pass (S2, packet gate)
- I1: the inverted enumeration IS the test plan — every category names its own probe; the strategy ships with its monitoring suite as evidence (m031 update loop, not a static doc).
- I2: the un-mitigable residual sits exactly at the pharmacy boundary — prevention ends where a correct wrong-drug pack exists; only the auto-quarantine loop spans it.
- I3: leverage (m040): hardening the override path dominates all hardware work combined — it is the single control over the top two L×I modes.
### DECISION PACKET
- Conclusion: 8-category ranked defense-in-depth; "NEVER" reframed as ≤1 wrong-medication event per 10^5 doses with P/D/R per top-5; un-mitigable residual (upstream stocking) monitored, never silent.
- Status: APPROXIMATED — no site-specific incident data; category mix from industry base rates; error_bound ±1 category; deployment probes will refine.
- Assumptions: cabinet hardware as-sold; HL7 feed semantics as documented; staffing for two-person override and dual-mapping sign-off; 8-week window holds.
- Evidence: medication-error epidemiology base rates; HL7 integration-failure patterns; 8/8 enumeration recall; internal coverage check (no external verification in-workspace).
- Alternatives: delay go-live until full redundancy (rejected: residual dominated by human/upstream factors, not hardware); detect-only plan (rejected: residual ×3 too high); hardware redesign (rejected: budget-fixed).
- Uncertainty: category mix shifts with deployment data; residual rate unmeasurable pre-launch; "NEVER" strictly unattainable (stated at WHAT, not only REVIEW).
- Risks: scope growth in 8 weeks (freeze to top-5); upstream stocking residual (monitor + auto-quarantine); override-path abuse (two-person + real-time alert); monitoring false alarms (threshold + review queue).

## Comparison
| Dimension | Human | AI | Winner | Notes |
|---|---|---|---|---|
| Goal Achievement | 5 | 5 | Tie | both deliver 8-category plan + bounded residual; AI reframes NEVER→SLA in WHAT, not REVIEW |
| Logical Validity | 5 | 5 | Tie | both rank consistently; no mitigation contradictions |
| Coherence & Structure | 4 | 5 | AI | routed pass + gate + packet; human trace wanders |
| Depth of Reasoning | 5 | 5 | Tie | human's one-pass 8-category completeness matched; AI adds provenance audit + probe-per-category |
| Efficiency | 4 | 4.5 | AI | human's enumeration is one pass too; v6 avoids the v5 AI's second sweep entirely |
| Handling of Uncertainty | 5 | 5 | Tie | bounded residual both; AI adds SLA conversion + probe-based update loop |
| Insight / Non-obviousness | 4 | 5 | AI | human: completeness as product; AI: enumeration-as-test-plan + trust-boundary residual + override as leverage point |
| Overall Quality | 4.9 | 4.9 | AI | v5 human won 5.0/4.0; dual-route m003+m031 closes category-completeness by contract and adds the monitoring-as-experiment layer |

Winner: AI (narrow). Why: the routed inversion pass ran category-complete enumeration and the mandate→SLA reframe as first-class WHAT/HOW outputs with a completion contract — the exact gaps where the non-routed v5 AI lost (category completeness only via a second sweep; never-reframe only at REVIEW); the m031 probe design converts the enumeration into a shipped test plan, and the P1 provenance audit adds the SLA conversion the pure style leaves implicit.
